Subscribe to Newsletter

Solutions for the Separation of Oligonucleotides

Separation of Oligonucleotides from Analytical to Process Scale

The oligonucleotide therapeutics field has seen remarkable progress over the last few years. The first antisense drug was approved and clinical trials using siRNA or splice switching oligonucleotide show promising developments.

The analytical separation of oligonucleotides as well as their purification following synthesis require
special considerations. These have been traditionally met by anion exchange chromatography. Specifically designed resins offer high resolution and selectivity and allow specific oligonucleotide extraction, analysis, purification and polishing.

Tosoh Bioscience offers different product lines for analytical and process scale applications that enable either specific isolation and analysis of oligonucleotides or the process scale purification thereof.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine